When confluent cells in culture are deprived of serum growth factors, the selective pathway of lysosomal proteolysis is activated (2, 3) . To determine whether overexpression of human LGP96 affected this proteolytic pathway, we radiolabeled control CHO cells with [1H] ileucine and transfected cells with [14C] Ieucine and then cultured both cell types on the same culture dishes to simultaneously follow degradation of 3H-and 14C-labeled proteins (14) . Proteolysis was increased in the transfected cells, both in the presence and absence of serum, when compared with the control CHO cells (Fig. 4A) . Similar results were obtained when control and transfected cells were analyzed in separate culture dishes (7) . Cells that expressed half the amount of human LGP96 as the transfectants shown in Fig. 4A also showed half the increased protein degradation rates when compared to those in CHO cells, and cells transfected with plasmid containing no cDNA degraded proteins at rates similar to those of the untransfected control cells (7) .
Several other aspects of the transfected cells were unaffected by overexpression of human LGP96. For example, the percentage of lysosomes broken during cell homogenization was similar in control and transfected cells (7) , and [3H]RNase A was taken up by cells and digested within endosomes and lysosomes at normal rates (Fig. 4B ). In addition, the cells grew at normal rates and had unaltered rates of protein synthesis (7) . Finally, lysosomes isolated from human LGP96-overexpressing cells were more active in the in vitro uptake and degradation of [14C] GAPDH under all conditions tested (Fig. 4C) .
Thus, overexpression of human LGP96 increased the activity of the selective lysosomal proteolytic pathway, and the level of LGP96 appears to be one rate-limiting component of the degradation machinery. It is not necessarily the only rate-limiting component, however, because overexpression of one protein may cause overexpression of interacting proteins (15) . Whether LGP96 plays a role in the selective uptake of proteins by lysosomes, in addition to the binding of substrate proteins, remains to be studied.
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IP3R staining in the dead cells was restricted to the area of the PM (Fig. 1 D) (14) , and stained with subtype-specific anti-IP3R1 and anti-IP. R3 before and after 48 hours of exposure to anti-lgM. Insets: WEHI cells, after exposure to anti-lgM, were stained with anti-IP R1 and anti-IP3R3 that had been blocked with an excess of IP,R1 peptide and IP R3 peptide, respectively. Results are from a representative experiment. Scale bar, 10 pm. Each experiment was done three times with similar results. (Fig. IF) . IP3R3 proteini almounts associated wsith were similar in control and apoptotic cells Antibodies to 11unigueLI C'tyoplasmlsi(c do-apoptosis that were 10 times those in con-( Fig. 2A) . Permeahilized anti-JgM-treated cells displayed a punctate distribution of IP3R3 immunoreactive staining along the region of the PM. In contrast, no increase in staining was evident with anti-IP3R1, and intracellular staining was diffuse (Fig. 2B) .
To determine the generality of the correlation of increased IP3R3 with apoptosis, we treated rat thymocytes and murine S49 thymoma cells with dexamethasone (15, 16) . The S49 cell line is highly sensitive to killing by glucocorticosteroids and has been extensively studied as a model for steroidinduced apoptosis (17) . In thymocytes and S49 cells treated with dexamethasone, the amounts of IP3R3 were 20 times and 5 times, respectively, those in controls; IP3R1 decreased in both cell types (Fig. 3, A and  B) . The IP3R2 in thymocytes and S49 cells decreased in both cell types after dexamethasone treatment (18) . Immunohistochemical analysis corroborated these findings (Fig. 3, C to E) . Before dexamethasone treatment, only IP3R1 was detected in thymocytes. After 12 hours of dexamethasone treatment, IP3R1 staining decreased and IP3R3 immunoreactivity in a second population of smaller cells was increased, with a punctate distribution along the PM. These results fit with the known greater sensitivity to glucocorticoid-induced apoptosis of the smaller, more immature cortical thymocytes relative to that of the larger, more mature medullary cells (15, 19) . In thymic sections, IP3R3 immunostaining was faint in control thymocytes but increased in cortical thymocytes after the rats received intraperitoneal injections of dexamethasone; no staining was observed in medullary regions (18) .
To determine the functional relation between elevations in IP3R3 and apoptosis, we constructed plasmids containing 5' portions of IP3R3 and IP3Rl in sense and antisense orientations (20) . Stably transfected cell lines were obtained by introducing dexamethasone-inducible and constitutively expressing plasmids into the T cell thymoma S49. Apoptosis was evoked by treatment with dexamethasone, which is well known to cause growth arrest and inhibit proliferation of S49 cells (17) . With either inducible or constitutive plasmids, cells expressing IP3R3 antisense were protected from glucocorticoid-induced apoptosis (Fig. 4 , B, C, E, and F) as monitored by light scatter analysis, [3H] thymidine incorporation (21) , and DNA fragmentation (17) . Cells transfected with IP3R3 sense and IP3R1 antisense constructs were not protected and underwent growth arrest and morphological changes associated with apoptosis. IP3R3 antisense protection against apoptosis was associated with an inhibition of the fivefold dexamethasone-induced increases in the amount of IP3R3 protein in apoptotic cells (Fig. 4, A and D (2, 3, 16) with axon diameter and is governed by axonal signals that are as yet not understood (1) . A number of transcription factors have been proposed to be involved in Schwann cell differentiation and myelination (2) . Prominent among those is the POU domain transcription factor Oct-6 (also known as SCIP or Tst-1) (3). The Oct-6 protein is expressed in the Schwann cells of the sciatic nerve and the sympathetic trunk from embryonic day 16 (El6) onward (4 
